The relative efficacy in vivo of the polymyxin and aminoglycoside antibiotics in experimental Pseudomonas infection has apparently never been established. This study was designed to determine such efficacy in experimental infection of mice. Eleven strains of Pseudomonas aeruginosa were selected for the study, representing six of the seven recognized immunotypes. All strains were susceptible to colistin, gentamicin, and tobramycin in vitro, and all were virulent for mice. None was lethal because of preformed toxins. Infections were established in mice by intraperitoneal (i.p.) injection of 100 ID50 of bacteria (infectious doses that would kill 50% of the mice). 
The relative efficacy of the polymyxin and aminoglycoside antibiotics has apparently never been rigorously established in the treatment of Pseudomonas aeruginosa infections in vivo (16) . Results of chemotherapy of human infections with P. aeruginosa have been poor, but patients with such infections usually have serious underlying diseases (10, 19, 32) . Few studies have been done on the activities of the polymyxins on experimental P. aeruginosa infections. Brownlee and Bushby found that polymyxin gave some protection against P. aeruginosa infections in mice, but it was less effective than streptomycin (7) . Sous (34) . Apparently no study has been published which systematically compares the polymyxins with gentamicin or tobramycin in the treatment of experimental P. aeruginosa infections.
The study to be presented was designed to determine whether strains of P. aeruginosa that are fully susceptible to the polymyxin and aminoglycoside antibiotics in vitro are also fully susceptible to these antibiotics in vivo.
The technique commonly called the mouse protection test was chosen as the principal method for in vivo evaluations. P. aeruginosa is known to produce many potent toxins (2, 3, 6, 8, (22) (23) (24) (25) (26) (27) (28) (29) 33) , and one is claimed to be responsible for death in experimental Pseudomonas infections (25 with 0.2 ml of tobramycin (50 mg/ml from Eli Lilly), 0.9 ml of bacterial suspension with 0.1 ml of 10% Formalin, 0.9 ml of bacterial suspension with 0.1 ml of 1 M HCl, and 0.9 ml of bacterial suspension with 1.0 ml of 95% ethyl alcohol. The four suspensions were then placed in a water bath at 37 C for 60 min. Sterility of the suspensions was confirmed by subculture on agar plates. The sterilized suspensions were mixed with equal volumes of 5% mucin, and 0.2 ml was injected i.p. into mice.
Control mice were injected with 3 x 108 living bacteria in mucin.
Antibiotic susceptibility tests in vivo. For chemotherapy studies, groups of mice were inoculated i.p. with bacterial suspensions in mucin that contained about 100 ID50. Mice were given graduated doses s.c.
of antibiotics or saline 1 h later. Mortality was determined after 48 h.
Intraperitoneal colony counts. To measure the influence of chemotherapy on numbers of bacteria in the peritoneal cavity, mice were inoculated i.p. with 100 ID,, of an overnight broth suspension. Preliminary studies indicated that the turbidity and virulence of overnight broth suspensions were similar to those of the 4-to 5-h cultures. One hour after .i.p.
inoculation, groups of mice were given s.c. injections of antibiotics or saline. At various intervals after i.p. inoculation mice were sacrificed with ether and 3 ml of brain heart infusion broth was injected into the peritoneal cavity. The abdomen was massaged vigorously and a midline incision was made into the peritoneal cavity using sterile techniques. Fluid was removed with a sterile 1-ml syringe. Numbers of viable bacteria were determined by colony count.
RESULTS
Virulence. Two strains were not studied for virulence because they were resistant to gentamicin in vitro. The virulence for mice of the other 19 strains is shown in Table 1 . An inoculum of 100 ID,0 was chosen for the mouse Table 3 . After inspection of the mortality curves from the acute toxicity trial, the maximum therapeutic dose for tobramycin Influence of the size of the bacterial inoculum on the response to chemotherapy in vivo. It is common knowledge that a large or heavy bacterial inoculum will usually decrease the apparent activity of an antibiotic in vitro (17) . The possibility was considered that the inoculum used in the mouse protection tests might be too "heavy," leading to an erroneous interpretation of "resistant" in vivo. To examine this question, groups of mice were inoculated i.p. with serial 10-fold dilutions of bacterial suspensions mixed with mucin. One hour later, mice were given s.c. injections of saline or antibiotics in a dosage of 30 mg/kg. The results for Pseudomonas strains 2a, 3b, 5c, and 7a are shown in Table 5 .
As an example of a strain that was highly susceptible to antibiotics both in vitro and in vivo, the results for Pseudomonas 5c are of interest. In this experiment, 5c was somewhat more virulent than before, and the inoculum of log 7.5 bacteria contained about 100 ID50. Tobramycin and colistimethate in a dosage of 30 Chemotherapy of infections with two strains of low virulence. Pseudomonas strains 6a and 6c were of particular interest because they exhibited the most extreme antagonism of antibiotics upon the addition of serum in vitro (13) . In the presence of 90% serum these two strains were able to grow in concentrations of gentamicin or tobramycin at 5.0,g/ml. However, these two strains were excluded from the mouse protection tests presented above because were injected s.c. with saline or antibiotic. At intervals mice were sacrificed, and the peritoneal cavities were washed with broth. The numbers of viable bacteria were determined by colony count. Results are presented in Fig. 1 .
Mice treated with saline had a steady increase in the number of bacteria in the peritoneal cavity. Administration of tobramycin at 30 mg/kg, a dose that is curative for mice infected with this strain (see Table 4 ), led to a rapid decline in the number of i.p. bacteria. Treatment with colistimethate, 30 mg/kg, a dose that did not cure mice infected with this strain (see Table 4 ), was followed by an increase in the number of bacteria. These findings appear to exclude the delayed release of toxins as a cause for colistimethate failure.
DISCUSSION
This study demonstrates a dissociation for some strains of P. aeruginosa between the results of in vitro antibiotic susceptibility tests and mouse protection tests. Several possible causes of error in interpretation were considered and excluded. Preformed toxins were ruled out as a cause of antibiotic failure because bacterial suspensions sterilized by six different methods were not lethal for mice. Because antibiotics were given 1 h after inoculation with bacteria, bacterial lysis resulting in a release of lethal toxins was also considered. Death due to delayed release of toxins was excluded by the demonstration that colistimethate failure was accompanied by rising i.p. bacterial counts.
Another possible source of misinterpretation is the bacterial inoculum. A "heavy" inoculum may cause a susceptible organism to be erroneously classified as resistant to antibiotics by in vitro tests (17) . Little seems to be known about the influence of the size of Pseudomonas inoculum on antibiotic susceptibility in vivo. The data presented here and from one other paper (1) indicate that the use of a "heavier" bacterial inoculum may decrease the apparent effectiveness of an antibiotic in vivo.
An inoculum of 100 ID50 was used in this study because an inoculum of 10 ID50 resulted in only an average 74% mortality (Table 1) . Intuitively, it seemed essential that the bacterial inocula for all 11 strains in mouse protection tests should be the same in terms of virulence.
This study and one recent report show that strains of P. aeruginosa vary widely in virulence (20) .
There appears to be no general agreement among investigators as to the optimal bacterial inoculum for mouse protection tests. In one 10- study, all mice were inoculated with 107 organisms without reference to virulence (37). Wick and Weller compared gentamicin, kanamycin, and tobramycin (formerly nebramycin) in mouse protection tests, using bacterial inocula ranging from 10 to 10,000 ID50 (38) . Further investigation may well show that 100 ID,0 is too heavy an inoculum for P. aeruginosa, resulting in a too rigorous test in vivo. Use of a lighter inoculum probably would have decreased the number of strains appearing to be resistant in vivo. However, colistimethate failed with several strains of P. aeruginosa even when a "light" inoculum was used.
Colistimethate must be hydrolyzed to the base to acquire antibiotic activity. This fact might be a partial explanation for the poor results obtained with colistimethate. Two other points tend to discount this explanation. Colistimethate was highly effective in treatment of murine infections with E. coli and Klebsiella (34) . Furthermore, little antibiotic activity was detected after 8 h as determined by i.p. counts (Fig. 1) .
The cause for the dissociation between in vitro and in vivo activity must remain a subject for speculation for the present. The activity in vitro of the polymyxins and aminoglycosides on P. aeruginosa is antagonized, to a variable degree, by Ca2+ and other factors in serum (9, 11-15, 30, 31, 40 The data available appear to exclude preformed toxins as a lethal factor in experimental murine infections (4, 8, 20) . Toxins must become significant only after the infection is established.
By exclusion, this finding is compatible with the concept that P. aeruginosa initiates disease primarily by multiplication and not by intoxication. This concept is also supported by the work of Kobayashi on two strains of P. aeruginosa exhibiting high and low virulence for mice (21) . The strain exhibiting high virulence was resistant to i.p. phagocytosis and grew rapidly in the animals. The strain with low virulence was quickly phagocytosed i.p. and rapidly cleared from the animals. He concluded that virulence of Pseudomonas was related to the capacity of the organisms to multiply i.p. and to resist phagocytosis.
The evidence against exotoxins as significant factors in the initiation of Pseudomonas infections also supports the conclusions of Young and Armstrong concerning the interaction of P. aeruginosa with human leukocytes and serum factors (39) . They suggested that antibody and complement dependent phagocytosis in killing of P. aeruginosa may be the most significant factors in the resistance to this organism in man.
The constituents of P. aeruginosa that account for virulence of the organism have not been identified. One factor may be the slime which has been reported to resist phagocytosis (35) and enhance the virulence of Pseudomonas in i.p. murine infections (21) .
